New Research Poster Presentation 1.43: Add-On Lamotrigine (LTG) in Youth with Bipolar I Disorder: Preliminary Results From the Open-Label Phase

Wednesday, October 28, 2009 10:00 AM

Joseph Horrigan, M.D., Neurosciences Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC

Vicki J. Foster, M.P.H., Neurosciences Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC

Robert L. Findling, M.D., University Hospitals Case Medical Center, Cleveland, OH

Tara Dudley, M.S., Neurosciences Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 1.43 Add-On Lamotrigine (LTG) in Youth with Bipolar I Disorder: Preliminary Results From the Open-Label Phase